These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
4. [IL-1Ra: its role in rheumatoid arthritis]. Cutolo M Reumatismo; 2004; 56(1 Suppl 1):41-5. PubMed ID: 15201939 [TBL] [Abstract][Full Text] [Related]
5. IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis. Gabay C Expert Opin Investig Drugs; 2000 Jan; 9(1):113-27. PubMed ID: 11060665 [TBL] [Abstract][Full Text] [Related]
6. [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy]. Fiocco U; Vezzù M; Cozzi L; Todesco S Reumatismo; 2004; 56(1 Suppl 1):62-73. PubMed ID: 15201942 [TBL] [Abstract][Full Text] [Related]
7. The balance between IL-1 and IL-1Ra in disease. Arend WP Cytokine Growth Factor Rev; 2002; 13(4-5):323-40. PubMed ID: 12220547 [TBL] [Abstract][Full Text] [Related]
8. [Biological modulation of IL-1 activity: role and development of its natural inhibitor IL-1Ra]. Dayer JM Reumatismo; 2004; 56(1 Suppl 1):3-8. PubMed ID: 15201935 [TBL] [Abstract][Full Text] [Related]
9. Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A. Ayer LM; Issekutz AC; Waterhouse CC; Stadnyk AW Inflammation; 2000 Oct; 24(5):447-61. PubMed ID: 10921508 [TBL] [Abstract][Full Text] [Related]
10. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360 [TBL] [Abstract][Full Text] [Related]
11. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626 [TBL] [Abstract][Full Text] [Related]
12. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Dayer JM Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089 [TBL] [Abstract][Full Text] [Related]
13. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. Chomarat P; Vannier E; Dechanet J; Rissoan MC; Banchereau J; Dinarello CA; Miossec P J Immunol; 1995 Feb; 154(3):1432-9. PubMed ID: 7822808 [TBL] [Abstract][Full Text] [Related]
14. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. McColl SR; Paquin R; Ménard C; Beaulieu AD J Exp Med; 1992 Aug; 176(2):593-8. PubMed ID: 1386877 [TBL] [Abstract][Full Text] [Related]
15. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation. Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194 [TBL] [Abstract][Full Text] [Related]
16. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. Horai R; Saijo S; Tanioka H; Nakae S; Sudo K; Okahara A; Ikuse T; Asano M; Iwakura Y J Exp Med; 2000 Jan; 191(2):313-20. PubMed ID: 10637275 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate. Seitz M; Zwicker M; Villiger PM J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386 [TBL] [Abstract][Full Text] [Related]
18. Physiologic role of interleukin-1 receptor antagonist. Arend WP; Gabay C Arthritis Res; 2000; 2(4):245-8. PubMed ID: 11094434 [TBL] [Abstract][Full Text] [Related]
19. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. Barrera P; van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van Lent PL; van de Putte LB; Corstens FH Rheumatology (Oxford); 2000 Aug; 39(8):870-4. PubMed ID: 10952741 [TBL] [Abstract][Full Text] [Related]